• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 5
      Zanidatamab shows promise as first-line therapy for advanced-stage HER2+ GEA - 18 day(s) ago

      Nature Reviews Clinical Oncology – Zanidatamab shows promise as first-line therapy for advanced-stage HER2+ GEA

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Zanidatamab shows promise as first-line therapy for advanced-stage HER2+ GEA https://t.co/fl2gFcvTAB

    • Mashup Score: 5
      Second-line tarlatamab improves OS in SCLC - 19 day(s) ago

      Nature Reviews Clinical Oncology – Second-line tarlatamab improves OS in SCLC

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Second-line tarlatamab improves OS in SCLC https://t.co/9aMEzqk57O

    • Mashup Score: 1
      Robot-assisted laparoscopic surgery confers improved oncological outcomes - 19 day(s) ago

      Nature Reviews Clinical Oncology – Robot-assisted laparoscopic surgery confers improved oncological outcomes

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Robot-assisted laparoscopic surgery confers improved oncological outcomes https://t.co/TjPvOs6wIE

    • Mashup Score: 2
      Adding durvalumab to perioperative FLOT improves gastric cancer outcomes - 19 day(s) ago

      Nature Reviews Clinical Oncology – Adding durvalumab to perioperative FLOT improves gastric cancer outcomes

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Adding durvalumab to perioperative FLOT improves gastric cancer outcomes https://t.co/Q0NXk3O7sq

    • Mashup Score: 9
      The next generation of immunotherapies for lung cancers - 19 day(s) ago

      Nature Reviews Clinical Oncology – Immune-checkpoint inhibitors (ICIs) have improved lung cancer outcomes, although resistance to these agents presents a substantial challenge. This Review…

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! The next generation of immunotherapies for lung cancers https://t.co/B9fBTfQRlG

    • Mashup Score: 43
      Promises and pitfalls of multi-cancer early detection using liquid biopsy tests - 23 day(s) ago

      Nature Reviews Clinical Oncology – Liquid biopsy-based tests have demonstrated potential as a minimally invasive and broadly applicable approach to simultaneously screen individuals for multiple…

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Promises and pitfalls of multi-cancer early detection using liquid biopsy tests https://t.co/4Xvhmqf9rl

    • Mashup Score: 13
      Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC - 23 day(s) ago

      Nature Reviews Clinical Oncology – Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC https://t.co/fX8wFE0rDB

    • Mashup Score: 13
      Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC - 24 day(s) ago

      Nature Reviews Clinical Oncology – Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC https://t.co/fX8wFE0rDB

    • Mashup Score: 1
      T-DXd effective as second-line therapy in G/GEJ cancers - 24 day(s) ago

      Nature Reviews Clinical Oncology – T-DXd effective as second-line therapy in G/GEJ cancers

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! T-DXd effective as second-line therapy in G/GEJ cancers https://t.co/nF0uAlh0qs

    • Mashup Score: 4
      A new first-line standard-of-care for BRAFV600E-mutated mCRC - 24 day(s) ago

      Nature Reviews Clinical Oncology – A new first-line standard-of-care for BRAFV600E-mutated mCRC

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! A new first-line standard-of-care for BRAFV600E-mutated mCRC https://t.co/aIX7LaLK8V

    Load More

    NatureRevClinOncol

    @NatRevClinOncol

    The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings